Small intestinal motility

Current Opinion in Gastroenterology

Volumn 24, Issue 2, 2008, Pages 164-172

  Jones, Michael P ^a,b   Bratten, Jason R ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NONE   (United States)

Author keywords

Bacterial overgrowth; Motility; Pseudoobstruction; Small intestine

Indexed keywords

ALVIMOPAN; ANTIINFECTIVE AGENT; CEFTRIAXONE; ERYTHROMYCIN; RIFAXIMIN; SOMATOSTATIN;

ACROMEGALY; BACTERIAL OVERGROWTH; BLADDER CONTRACTION; BLOATING; CHOLELITHIASIS; CLINICAL ASSESSMENT; CLINICAL FEATURE; CLINICAL TRIAL; COLORECTAL TUMOR; DISEASE ASSOCIATION; ELECTROSTIMULATION; ENTERITIS; HUMAN; HYPOPHYSIS ADENOMA; ILEUS; INTESTINAL DYSMOTILITY; INTESTINE INFECTION; INTESTINE INNERVATION; INTESTINE MOTILITY; INTESTINE PSEUDOOBSTRUCTION; IRRITABLE COLON; MNGIE SYNDROME; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; REVIEW; SCLERODERMA; SIDE EFFECT; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

GASTROINTESTINAL MOTILITY; HUMANS; INTESTINAL DISEASES; INTESTINE, SMALL;

EID: 40049087707     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOG.0b013e3282f33f5c     Document Type: Review

References (41)

1. Esfandyari T, Camilleri M, Ferber I, et al. Effect of a cannabinoid agonist on gastrointestinal transit and postprandial satiation in healthy human subjects: a randomized, placebo-controlled study. Neurogastroenterol Motil 2006; 18:831-838.
2. Popovic V, Miljic D, Pekic S, et al. Low plasma ghrelin level in gastrectomized patients is accompanied by enhanced sensitivity to the ghrelin-induced growth hormone release. J Clin Endocrinol Metab 2005; 90:2187-2191.
3. Wierup N, Bjorkqvist M, Westrom B, et al. Ghrelin and motilin are co-secreted from a prominent endocrine cell population in the small intestine. J Clin Endocrinol Metab 2007; 92:3573-3581.
4. Schmidt PT, Degerblad M, Lindstrom E, et al. Circulating ghrelin levels after food intake during different phases of the migrating motor complex in man. Eur J Clin Invest 2006; 36:503-508.
5. Tack J, Depoortere I, Bisschops R, et al. Influence of ghrelin on interdigestive gastrointestinal motility in humans. Gut 2006; 55:327-333.
6. Venkova K, Fraser G, Hoveyda HR, Greenwood-Van Meerveld B. Prokinetic effects of a new ghrelin receptor agonist TZP-101 in a rat model of postoperative ileus. Dig Dis Sci 2007; 52:2241-2248.
7. Lee HT, Hennig GW, Fleming NW, et al. The mechanism and spread of pacemaker activity through myenteric interstitial cells of Cajal in human small intestine. Gastroenterology 2007; 132:1852-1865. A novel and important study using human tissue to demonstrate the mechanisms by which ICC pacemaker impulses are generated and entrained.
8. Storch I, Barkin JS. Contraindications to capsule endoscopy: do any still exist? Gastrointest Endosc Clin N Am 2006; 16:329-336.
9. Hoog CM, Lindberg G, Sjoqvist U. Findings in patients with chronic intestinal dysmotility investigated by capsule endoscopy. BMC Gastroenterol 2007; 7:29.
10. Hung GU, Tsai CC, Lin WY. Development of a new method for small bowel transit study. Ann Nucl Med 2006; 20:387-392.
11. Patak MA, Froehlich JM, von Weymarn C, et al. Noninvasive measurement of small-bowel motility by MRI after abdominal surgery. Gut 2007; 56:1023-1025. A novel study using MRI to evaluate and characterize postsurgical intestinal motility.
12. Sjolund K, Bartosik I, Lindberg G, et al. Small intestinal manometry in patients with systemic sclerosis. Eur J Gastroenterol Hepatol 2005; 17:1205-1212.
13. Gregersen H, Liao D, Pedersen J, Drewes AM. A new method for evaluation of intestinal muscle contraction properties: studies in normal subjects and in patients with systemic sclerosis. Neurogastroenterol Motil 2007; 19:11-19. Further application of a novel device combining manometry, impedance planimetry and balloon distension to evaluate the mechanical and muscular properties of duodenum in patients with scleroderma.
14. Marie I, Ducrotte P, Denis P, et al. Outcome of small-bowel motor impairment in systemic sclerosis: a prospective manometric 5-yr follow-up. Rheumatology (Oxford) 2007; 46:150-153. This longitudinal assessment of small intestinal motility in scleroderma is an important addition to the literature in this area.
15. Resmini E, Parodi A, Savarino V, et al. Evidence of prolonged orocecal transit time and small intestinal bacterial overgrowth in acromegalic patients. J Clin Endocrinol Metab 2007; 92:2119-2124.
16. Blondon H, Polivka M, Joly F, et al. Digestive smooth muscle mitochondrial myopathy in patients with mitochondrial-neuro-gastro-intestinal encephalomyopathy (MNGIE). Gastroenterol Clin Biol 2005; 29 (8-9):773-778.
17. Giordano C, Sebastiani M, Plazzi G, et al. Mitochondrial neurogastrointestinal encephalomyopathy: evidence of mitochondrial DNA depletion in the small intestine. Gastroenterology 2006; 130:893-901.
18. Anderson G, Noorian AR, Taylor G, et al. Loss of enteric dopaminergic neurons and associated changes in colon motility in an MPTP mouse model of Parkinson's disease. Exp Neurol 2007; 207:4-12.
19. McKeown ES, Parry SD, Stansfield R, et al. Postinfectious irritable bowel syndrome may occur after nongastrointestinal and intestinal infection. Neurogastroenterol Motil 2006; 18:839-843. A small series and intriguing observation suggesting that functional gastrointestinal disorders in general and IBS in particular may occur following both enteric and nonenteric infections.
20. Silva MA, de Meirelles LR, Bustorff-Silva JM. Changes in intestinal motility and in the myenteric plexus in a rat model of intestinal ischemia-reperfusion. J Pediatr Surg 2007; 42:1062-1065.
21. Ohlsson B, Veress B, Lindgren S, Sundkvist G. Enteric ganglioneuritis and abnormal interstitial cells of Cajal: features of inflammatory bowel disease. Inflamm Bowel Dis 2007; 13:721-726.
22. Delaney CP, Wolff BG, Viscusi ER, et al. Alvimopan, for postoperative ileus following bowel resection: a pooled analysis of phase III studies. Ann Surg 2007; 245:355-363.
23. Adolor Corporation. FDA accepts for review complete response to approvable letter for Entereg (alvimopan) for POI; 28 August 2007. http://phx.corporate-ir.net/phoenix.zhtml?c=120919&p=irol-newsArticle&t= Regular&id=1045484&. [Accessed 20 September 2007]
24. Lightfoot AJ, Eno M, Kreder KJ, et al. Treatment of postoperative ileus after bowel surgery with low-dose intravenous erythromycin. Urology 2007; 69:611-615.
25. Ceran C, Karadas B, Kaya T, et al. Do antibiotics contribute to postoperative ileus? Contractile responses of ileum smooth muscle in Guinea pigs to longterm parenteral ceftriaxone and ampicillin. Aust N Z J Surg 2006; 76:1023-1026.
26. Gonlachanvit S, Coleski R, Owyang C, Hasler WL. Nutrient modulation of intestinal gas dynamics in healthy humans: dependence on caloric content and meal consistency. Am J Physiol Gastrointest Liver Physiol 2006; 291:G389-G395.
27. Harder H, Hernando-Harder AC, Franke A, et al. Effect of acute hyperglycemia on intestinal gas transit and tolerance in nondiabetic humans. Digestion 2005; 71:179-186.
28. Harder H, Hernando-Harder AC, Franke A, et al. Duodenal infusion of different nutrients and the site of gaseous stimulation influence intestinal gas dynamics. Scand J Gastroenterol 2006; 41:294-301.
29. Salvioli B, Serra J, Azpiroz F, Malagelada JR. Impaired small bowel gas propulsion in patients with bloating during intestinal lipid infusion. Am J Gastroenterol 2006; 101:1853-1857. Infusion of duodenal lipids inhibits intestinal gas transit in the jejunum but not ileum.
30. Tremolaterra F, Villoria A, Serra J, et al. Intestinal tone and gas motion. Neurogastroenterol Motil 2006; 18:905-910. Duodenal barostat study demonstrates that ingested lipids decrease wall tone while gas infusion increases wall tone and may contribute to gas propulsion.
31. Perez F, Accarino A, Azpiroz F, et al. Gas distribution within the human gut: effect of meals. Am J Gastroenterol 2007; 102:842-849. A novel computed tomographic technique that assesses the distribution of intestinal gas before and after meals and provides unique insight into intestinal gas handling.
32. Fernandez-Banares F, Rosinach M, Esteve M, et al. Sugar malabsorption in functional abdominal bloating: a pilot study on the long-term effect of dietary treatment. Clin Nutr 2006; 25:824-831.
33. Villoria A, Serra J, Azpiroz F, Malagelada JR. Physical activity and intestinal gas clearance in patients with bloating. Am J Gastroenterol 2006; 101:2552-2557.
34. Rosa ESL, Gerson L, Davila M, Triadafilopoulos G. Clinical, radiologic, and manometric characteristics of chronic intestinal dysmotility: the Stanford experience. Clin Gastroenterol Hepatol 2006; 4:866-873.
35. Andersson S, Lonroth H, Simren M, et al. Gastric electrical stimulation for intractable vomiting in patients with chronic intestinal pseudoobstruction. Neurogastroenterol Motil 2006; 18:823-830.
36. Simren M, Stotzer PO. Use and abuse of hydrogen breath tests. Gut 2006; 55:297-303. An excellent review of hydrogen breath testing in clinical practice that should be read by any clinician interested in this diagnostic technique, particularly with regards to IBS.
37. Walters B, Vanner SJ. Detection of bacterial overgrowth in IBS using the lactulose H2 breath test: comparison with 14C-D-xylose and healthy controls. Am J Gastroenterol 2005; 100:1566-1570.
38. Posserud I, Stotzer PO, Bjornsson ES, et al. Small intestinal bacterial overgrowth in patients with irritable bowel syndrome. Gut 2007; 56:802-808. A large, elegant study that calls into question the role of bacterial overgrowth and small intestinal motility disturbances in patients with IBS.
39. Sharara AI, Aoun E, Abdul-Baki H, et al. A randomized double-blind placebo-controlled trial of rifaximin in patients with abdominal bloating and flatulence. Am J Gastroenterol 2006; 101:326-333.
40. Pimentel M, Park S, Mirocha J, et al. The effect of a nonabsorbed oral antibiotic (rifaximin) on the symptoms of the irritable bowel syndrome: a randomized trial. Ann Intern Med 2006; 145:557-563.
41. Dear KL, Elia M, Hunter JO. Do interventions which reduce colonic bacterial fermentation improve symptoms of irritable bowel syndrome? Dig Dis Sci 2005; 50:758-766.